Scanadu
| Type of business | Private company |
|---|---|
| Founded | 2011, Silicon Valley |
| Headquarters | Sunnyvale, CA |
| Founder(s) | Walter De Brouwer, Misha Chellam |
| Employees | <50 |
| Website | www.scanadu.com |
Scanadu is a Silicon Valley-based company developing next generation tests, devices, and services that empower anyone to monitor and better understand their own health - anytime, anywhere. Scanadu is identifying the latest advances in the life sciences and applying its expertise in artificial intelligence, product design and user experience, hardware, software, clinical, and regulatory to bring to market ambitious and ground-breaking medical solutions for consumers. It was founded in February 2011 by Walter De Brouwer and Misha Chellam in Silicon Valley. In mid 2011, Scanadu set up a lab at NASA Ames Research Center in Mountain View, Calif., to help grow the company. It relocated to Sunnyvale, CA in September 2016.
A prototype of Scanadu’s first product, the Scanadu Scout, was unveiled on November 29, 2012. The Scanadu Scout is a portable electronic device for consumer use designed to measure different physiological parameters, including temperature, heart rate, blood oxygenation, respiratory rate, ECG, and diastolic/systolic blood pressure. Scanadu’s goal was to make the Scanadu Scout available by March 2014 as an investigational device to those who participated in the Indiegogo crowdfunding campaign and agreed to participate in a research study, and afterwards, to general consumers by Q1 of 2015. Scanadu is seeking approval by the U.S. Food and Drug Administration (FDA) for the device before bringing it to market to ensure clinical-grade accuracy. Scanadu missed the initial shipping deadline; the devices finally began shipping in February 2015. In April 2016, Scanadu stated that the clinical trial with over 4,000 participants was ongoing, however in December 2016 they sent a message to the study subjects stating that the initial device has supported extensive data collection; and the Scout investigational device would only be supported until the end of the study, after which it would cease to function.
On November 29, 2012, the company unveiled a suite of new tools to “revolutionize consumer healthcare.” The Scanadu Scout is a lightweight device that is touched to a patient’s temple and is touted as being able to return key vital sign results in less than 10 seconds. Project ScanaFlo is a urinanalysis test for conditions like preeclampsia, gestational diabetes, kidney failure and urinary tract infections. Project ScanaFlu is used when a patient is exhibiting cold-like symptoms. The saliva test checks for Strep A, Influenza A and B, adenovirus, and RSV. The suite of products, originally conceived of in partnership with IDEO, is being designed by award-winning industrial designer Yves Behar.
...
Wikipedia